Elevated Plasma Platelet Activating Factor, Platelet Activating Factor Acetylhydrolase Levels and Risk of Coronary Heart Disease or Blood Stasis Syndrome of Coronary Heart Disease in Chinese: A Case Control Study-Reference-Cited by-同舟云学术

Elevated Plasma Platelet Activating Factor, Platelet Activating Factor Acetylhydrolase Levels and Risk of Coronary Heart Disease or Blood Stasis Syndrome of Coronary Heart Disease in Chinese: A Case Control Study

Published:2012-03-20 Issue:4 Volume:35 Page:1419-1428
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Zheng Guo-Hua,Xiong Shang-Quan,Mei Li-Juan,Chen Hai-Ying,Wang Ting,Chu Jian-Feng

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10753-012-9455-4.pdf

Reference48 articles.

1. Ross, R. 1999. Atherosclerosis: an inflammatory disease. The New England Journal of Medicine 340(2): 115–126.

2. Blake, G.J., and P.M. Rider. 2002. Inflammatory bio-markers and cardiovascular risk prediction. Journal of Internal Medicine 252: 283–294.

3. Welch, E.J., R.P. Nalkawadi, Z. Li, P. Lin, S. Ishii, et al. 2009. Opposing effects of platelet-activating factor and lyso-platelet activating factor on neutrophil and platelet activation. Molecular Pharmacology 75: 227–234.

4. Uhlig, S., R. Goggel, and S. Engel. 2005. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. Pharmacological Reports 57(suppl): 206–221.

5. Vadas, P., M. Gold, B. Perelman, and G.M. Liss. 2008. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. The New England Journal of Medicine 358: 28–35.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A2 and C-reactive protein: a cross-sectional study;European Journal of Nutrition;2023-12-08

2. The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study;Nutrition & Metabolism;2023-09-12

3. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome;Brain Research Bulletin;2023-09

4. Discovery of Drug-Responsive Phenomic Alteration-Related Driver Genes in the Treatment of Coronary Heart Disease;Pharmacogenomics and Personalized Medicine;2023-03

5. Interrelationships among platelet‐activating factor and lipoprotein‐associated phospholipase A ₂ activity and traditional cardiovascular risk factors;BioFactors;2022-12-20